Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
20 participants
INTERVENTIONAL
2006-07-31
2029-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Phase II Study of Midodrine for Neurogenic Orthostatic Hypotension
NCT00004268
Intravenous Norepinephrine for Orthostatic Hypotension
NCT01285908
Study to Assess the Benefit of Midodrine in the Treatment of Patients With Neurogenic Orthostatic Hypotension
NCT00555880
A Study in Subjects With Neurogenic Orthostatic Hypotension
NCT07089043
Water and Sudafed in Autonomic Failure
NCT02149901
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
16 oz water in AM
water high dose
water 16 oz PO x 1
2
water 1 oz in AM
water tiny dose
water 1 oz PO x 1
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
water high dose
water 16 oz PO x 1
water tiny dose
water 1 oz PO x 1
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* pressor response to water in other studies
* Age 18-80 years
Exclusion Criteria
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Satish R. Raj
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Satish R. Raj
Assistant Professor of Medicine & Pharmacology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Satish R Raj, MD MSCI
Role: PRINCIPAL_INVESTIGATOR
Vanderbilt University Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Vanderbilt University
Nashville, Tennessee, United States
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Vanderbilt Autonomic Dysfunction Center website
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Vanderbilt Discovery
Identifier Type: OTHER
Identifier Source: secondary_id
060547
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.